MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202631111515 A) filed by Raj Kumar Mandal on September 17, 2026, for A Ph-Responsive And Enzyme-Responsive Nanoparticulate Drug Delivery System For Targeted Release Of Antiretroviral Therapeutic Agents At Sites Associated With Human Immunodeficiency Virus Infection.
Inventors include Mr. Yogesh R; Ms. Tejaswini Jinagam; Mr. Mathan Kumar T; Ms. Kiruthigaa Sri; Ms. Hemarakshika S; Ms. D. Rajeswari; Ms. Siddhi Sachin Waingankar; Mr. Jeeva T; Ms. Dharshini Priya P; and Mr. Raj Kumar Mandal.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: [34] The present invention discloses pH-responsive and enzyme-responsive nanoparticulate carriers designed for controlled delivery of antiretroviral therapeutic agents at sites associated with human immunodeficiency virus infection. The nanocarriers comprise biodegradable materials incorporating stimulus-sensitive components that regulate drug liberation in response to acidic pH and enzymatic conditions. These nanoparticles exhibit dimensions, drug-loading capacity, stability and controlled release kinetics, enabling prolonged therapeutic activity with reduced premature release. By supporting formulation composition and administration routes, the invention provides a biocompatible platform for responsive antiretroviral delivery that may improve spatial and temporal control of exposure.
Disclaimer: Curated by HT Syndication.
